Matthew L. Ryan

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The organisms reported to cause myocarditis and pericarditis in England and Wales

Christopher K. Fairley, Matthew L. Ryan, Patrick Wall et al. · Journal of Infection · 1996 · 63 citations

Veterinary Medicine, Cardiology, Infectious Diseases +7

Age dependence of pilocarpine-induced status epilepticus and inhibition of CaM kinase II activity in the rat

Michael W. Singleton, William H. Holbert, Matthew L. Ryan et al. · Developmental Brain Research · 2005 · 17 citations

Medicine, Neuroscience, Pharmacology +11

Case of mononeuritis multiplex onset with rituximab therapy for Waldenström's macroglobulinemia

Michelle L. Mauermann, Matthew L. Ryan, Joon-Shik Moon et al. · Journal of the Neurological Sciences · 2007 · 16 citations

Life Sciences, Immunology, Pharmacotherapy +8